Lisata Therapeutics, Inc. LSTA 深 沪
已收盘 03-27 16:00:00 美东时间
5.02
0.000
0.00%
华盛通- 最 高5.02
- 今 开5.02
- 成交量 1.43万股
- 最 低 5.01
- 昨 收 5.02
- 总市值 4428.01万
- 52周最高 5.07
- 市盈率 静 --
- 换手率 0.16%
- 52周最低 1.81
- 委 比 21.52%
- 总股本 882.07万
- 历史最高 1483.50
- 量 比 0.36
- 振 幅 0.20%
- 历史最低 1.81
- 每 手 1
- 风险率 0.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Lisata Therapeutics announced it has agreed to be acquired by Kuva Labs for $5.00 per share in cash plus an additional $1.00 per share contingent on a future milestone. The board recommends stockholders tender shares, with the deal expected to close in Q2 2026. Upon completion, Lisata will become part of Kuva and delist from Nasdaq.
03-06 23:15
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
02-12 09:02
Lisata Therapeutics ends Qilu certepetide collaboration deal
Lisata Therapeutics ( ($LSTA) ) just unveiled an announcement. On January 23, 2...
01-27 21:48
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks staged a modest recovery on Wednesday after the sharpest equities se
01-22 02:53
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers PAVmed (NASDAQ:PAVM) stock increased by 250.7% to $21.71 during Wednes...
01-22 01:05
Brookline Capital Downgrades Lisata Therapeutics to Hold
Brookline Capital analyst Kemp Dolliver downgrades Lisata Therapeutics (NASDAQ:LSTA) from Buy to Hold.
01-22 00:04
BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks staged a modest recovery on Wednesday after the sharpest e
01-21 23:49
Why Is Lisata Therapeutics Stock Gaining Today?
Lisata Therapeutics shares surged premarket after Kuva Labs agreed to acquire the company for $4 per share in cash plus two milestone-based CVRs.
01-21 23:31
Lisata Therapeutics To Be Acquired By Kuva Labs In $4.00/Share Tender Offer
Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain milestonesOffer represents an approximate 85% premium over the most recent
01-21 20:03
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Lisata Therapeutics has entered into a binding term sheet to be acquired by Kuva Labs for $4.00 per share in cash, representing an 85% premium over its recent stock price. Shareholders will also receive two contingent value rights (CVRs) worth $1.00 each, contingent on certain milestones. The transaction, approved by both companies' boards, values Lisata's clinical pipeline and lead product certepetide, a novel anti-cancer therapy. Kuva plans to ...
01-21 12:00
